US$ 27.21
glp-1/gip receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Targeting GLP-1, GIP & GCG
Description
Any views expressed in this article reflect current scientific understanding as of the publication date and may evolve with further research

A patient arrives having heard about Wegovy or Mounjaro perhaps from a news article, perhaps from a friend who has lost significant weight, and the discussion centres almost entirely on efficacy and tolerability
Pick one time each day to try

Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier

Murine models of heart failure with preserved ejection fraction: a fishing expedition. JACC Basic Transl Sci
